Search for: "Bristol-Meyers Squibb Company"
Results 21 - 38
of 38
Sort by Relevance
|
Sort by Date
31 Jan 2015, 8:47 pm
The issue of what, exactly, is ‘implicitly’ disclosed in a prior art reference arises in a decision of a full bench of the Federal Court issued on 23 January 2015 (Bristol-Myers Squibb Company v Apotex Pty Ltd [2015] FCAFC 2) in an appeal relating to a long-running dispute over the validity of a patent covering the antipsychotic drug aripiprazole. [read post]
3 Oct 2014, 7:55 am
” In re Bristol Meyers Squibb Co. [read post]
21 Aug 2013, 9:05 am
Also in Spring 2013, BDR Pharmaceuticals, Ltd. filed the 2nd Indian application for a CL (still pending) for Dasatinib, Bristol Meyers Squibb’s blockbuster anti-cancer drug. [read post]
29 Jul 2013, 10:05 am
Also in Spring 2013, BDR Pharmaceuticals, Ltd applied for a CL for Bristol Meyers Squibb’s anti-cancer drug Dasatinib. [read post]
5 Jun 2013, 5:29 am
Bristol-Meyers Squibb Co., 1998 WL 812318, at *23 (M.D. [read post]
12 Mar 2012, 5:41 pm
Bristol-Meyers Squibb Co. and Otsuka America Pharmaceutical, Inc., No. 12-cv-01124 (E.D.N.Y., Mar. 7, 2012) (Complaint) [read post]
16 Sep 2011, 11:02 am
The state has already settled cases with Astra Zeneca, Abbott Laboratories, GlaxoSmithKline, Amgen Inc., Baxter Healthcare Corp., Boehringer Ingelhelm Roxane, and Dey Pharmaceutical and has prevailed at trial against Johnson & Johnson and Bristol-Meyers Squibb. [read post]
14 Jun 2011, 7:01 am
Almost any contract signed with a large company now contains an arbitration clause. [read post]
2 Jun 2011, 12:46 pm
Squibb & Sons, Inc. v. [read post]
9 Mar 2011, 11:14 am
Bristol-Meyers Squibb Co., 156 N.J. 455, 463 (1998) (quoting N.J.R.E. 803(b)(4)). [read post]
26 Feb 2011, 1:36 pm
Gonzalez v Bristol-Meyers Squibb, 2011WL611722, Docket No. [read post]
18 Feb 2011, 11:47 am
., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
19 Oct 2010, 8:06 am
., dismissed one set of codefendants (related to Bristol-Meyers Squibb, or BMS), but found the relator’s complaint against AstraZeneca to be sufficiently particular under Rule 9(b). [read post]
7 Sep 2009, 12:06 pm
Eighteen months after the auction rate securities markets collapsed when Wall Street withdrew its support, companies like Bristol-Myers Squibb Co., Texas Instruments, Corning, and Teva Pharmaceuticals are still suffering from the Wall Street debacle. [read post]
17 Jul 2009, 2:29 pm
(Lynnfield, MA; Constantine Kalogianis, President) Adnexus, A Bristol-Myers Squibb R&D Company (Waltham, MA; Sonia Vora, President) Advanced Beauty Corporation (Braintree, MA; Hanna Le, President) Advanced Integrated Solutions Corp. [read post]
20 Mar 2009, 2:05 am
Squibb & Sons, Inc. v. [read post]
4 Oct 2007, 7:55 am
Last week we read a news release from the United States Department of Justice publicizing that Bristol-Meyers Squibb (BMS) had entered into a settlement agreement to pay more than $515 million to resolve allegations of illegal drug marketing and pricing. [read post]
30 Jul 2004, 1:33 pm
Bristol-Meyers Squibb, the leading US AIDs drugs manufacturer, agreed Friday to settle for $300 million shareholder lawsuits alleging that the company inflated its sales by more than $2 billion from 1999 to 2001. [read post]
